CHARLOTTESVILLE, Va., May 18, 2020 (GLOBE NEWSWIRE) -- Diffusion Pharmaceuticals Inc. (Nasdaq: DFFN) (“Diffusion” or “the Company”), a cutting-edge biotechnology company developing new treatments for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results